Cargando…
Impaired antibody response to COVID‐19 vaccination in patients with chronic myeloid neoplasms
Autores principales: | Chowdhury, Onima, Bruguier, Hannah, Mallett, Garry, Sousos, Nikolaos, Crozier, Kirsty, Allman, Caroline, Eyre, David, Lumley, Sheila, Strickland, Marie, Karali, Christina S., Murphy, Lauren, Sternberg, Alex, Jeffery, Katie, Mead, Adam J., Peniket, Andy, Psaila, Bethan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444839/ https://www.ncbi.nlm.nih.gov/pubmed/34132395 http://dx.doi.org/10.1111/bjh.17644 |
Ejemplares similares
-
The immune landscape in BCR‐ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy
por: Strickland, Marie, et al.
Publicado: (2021) -
Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology
por: Royston, Daniel, et al.
Publicado: (2021) -
Telemedicine and intraductal papillary mucinous neoplasms: Analysis of a new follow-up strategy during COVID-19 outbreak
por: Farguell, J., et al.
Publicado: (2022) -
Predicting and forecasting the impact of local outbreaks of COVID-19: use of SEIR-D quantitative epidemiological modelling for healthcare demand and capacity
por: Campillo-Funollet, Eduard, et al.
Publicado: (2021) -
Community factors and excess mortality in the COVID-19 pandemic in England, Italy and Sweden
por: Parkes, Brandon, et al.
Publicado: (2023)